SCHEMBL12004872

SCHEMBL12004872

CC(c1ccc(O)cc1)(c1ccc(O)cc1)c1ccc(-c2ccc(O)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.70
ESR2 Q92731 8/20 0.70
CYP3A4 P08684 2/20 0.59
LMNA P02545 1/20 0.59
TYR P14679 1/20 0.59
AR P10275 1/20 0.59
HPGD P15428 1/20 0.59
TSHR P16473 1/20 0.59
SLC6A2 P23975 1/20 0.59
SLC6A4 P31645 1/20 0.59
HTR6 P50406 1/20 0.59
ESRRG P62508 1/20 0.59
SLC6A3 Q01959 1/20 0.59
HSD17B10 Q99714 1/20 0.59
KIF11 P52732 1/20 0.58
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
ALDH1A1 P00352 1/20 0.50
SHBG P04278 1/20 0.48
MMP3 P08254 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10772499 1.00 ESR1 (0.70) ESR1ESR2CYP3A4LMNATYR
SCHEMBL26136547 1.00 ESR1 (0.70) ESR1ESR2CYP3A4LMNATYR
SCHEMBL461894 0.93 ESR1 (0.73) ESR1ESR2CYP3A4LMNATYR
SCHEMBL5604262 0.93 ESR1 (0.64) ESR1ESR2CYP3A4LMNATYR
SCHEMBL4063477 0.92 ESR1 (0.80) ESR1ESR2CYP3A4LMNATYR
SCHEMBL22335854 0.92 ESR1 (0.80) ESR1ESR2CYP3A4LMNATYR
SCHEMBL18750 0.92 ESR1 (0.80) ESR1ESR2CYP3A4LMNATYR
SCHEMBL10774292 0.91 ESR1 (0.59) ESR1ESR2CYP3A4LMNATYR
SCHEMBL10758787 0.91 ESR1 (0.79) ESR1ESR2CYP3A4LMNATYR
SCHEMBL6761025 0.89 ESR1 (0.76) ESR1ESR2CYP3A4LMNATYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115215734-B Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2024-01-05 CN claimed
CN-115215734-A Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2022-10-21 CN claimed
CN-115215734-B Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2024-01-05 CN disclosed
CN-115215734-B Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2024-01-05 CN disclosed
CN-115215734-B Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2024-01-05 CN disclosed
CN-115215734-A Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2022-10-21 CN disclosed
CN-115215734-A Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2022-10-21 CN disclosed
CN-115215734-A Preparation method of 1- [4- (4-hydroxyphenyl) phenyl ] -1, 1-bis (4-hydroxyphenyl) ethane 辽宁靖帆新材料有限公司 2022-10-21 CN disclosed
US-8816135-B2 Trisphenol compound HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2014-08-26 US disclosed
US-8816135-B2 Trisphenol compound HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2014-08-26 US disclosed
US-8816135-B2 Trisphenol compound HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2014-08-26 US disclosed
US-20120220805-A1 NOVEL TRISPHENOL COMPUND HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2012-08-30 US disclosed
US-20120220805-A1 NOVEL TRISPHENOL COMPUND HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2012-08-30 US disclosed
US-20120220805-A1 NOVEL TRISPHENOL COMPUND HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2012-08-30 US disclosed
WO-2011030835-A1 NOVEL TRISPHENOL COMPOUND 本州化学工業株式会社 (JP) 2011-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220805-A1 NOVEL TRISPHENOL COMPUND NCOR1, NCOR2, NCOA1 ESR1 40/4885ESR2 18/4885CYP3A4 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.